De-iron: A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes

  • Siddique, Shamyla (Co-Investigator)
  • Fenwick, Nicola (Principal Investigator)

Project Details

Short titleDe-iron: A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes
StatusFinished
Effective start/end date1/06/12 → 31/07/20

Funding

  • BLOODWISE
  • NOVARTIS PHARMACEUTICALS UK LTD